CraniUS Therapeutics Secures Second FDA 510(k) Clearance in Six Weeks and Earns U.S. Patent for NeuroPASS™ 3 Cranial Drug Delivery System

Newly cleared CraniUS® Plate configuration, designated NeuroPASS 2, adds an opening designed to accommodate an implantable intracranial pressure sensor; issued patent protects the integrated drug delivery architecture at the heart of NeuroPASS 3. BALTIMORE, Oct. 7, 2026 /PRNewswire/ --...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.